ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1166

Expression and Function of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (PIM-1) Kinase in Rheumatoid Arthritis Fibroblast-like Synoviocytes

Yong Seok Choi1, You Jung Ha2, Jaehyung Hur3, Eun Ha Kang4, Yeong Wook Song5 and Yun Jong Lee2, 1Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 2Division of Rheumatology, Department of Internal Medicine,Seoul National University Bundang Hospital, Seongnam, South Korea, 3Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 4Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Fibroblasts, matrix metalloproteinase (MMP) and rheumatoid arthritis, synovium

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The Proviral
Integration site of Moloney murine leukemia virus (PIM) kinases are important
mediators of cell survival and considered as attractive targets in cancer chemotherapy.
Their implication has not been studied in the function of rheumatoid arthritis
(RA)-fibroblast-like synoviocytes (FLS).

Methods: Immunoblot or
quantitative real-time RT-PCR was performed to investigate the expression of 3
isoforms of PIM kinases (PIM-1, PIM-2, and PIM-3) in of RA- and osteoarthritis
(OA)-FLS. The presence of PIM-1 was confirmed using immunostaining on synovial
tissue from RA and OA patients. After knockdown of PIM-1 using siRNA, proliferation
and migration assay were carried out. Additionally, matrix metalloproteinases (MMPs)
and interleukin (IL)-6 secretion was measured using ELISA from RA-FLS
transfected with control or PIM-1 siRNA.

Results: Among PIM kinases,
PIM-1 was most strongly induced by IL-6 stimulations in RA-FLS. The expression
of PIM-1 protein was higher in RA-FLS than in OA-FLS. In the synovial tissues
from RA patients, PIM-1 was immunostained in the synovial lining layer and
mononuclear cells (Fig. 1). When RA-FLS with PIM-1 knockdown were stimulated
with TNF-a, RA-FLS proliferation or migration was
significantly decreased (Fig. 2). Moreover, the production of MMP-1, MMP-3, and
MMP-13 was significantly suppressed in RA-FLSs with PIM-1 knockdown (Fig. 2).
IL-6 production from PIM-1 knockdown RA-FLS was also reduced, but statistically
insignificant.

Conclusion: These results suggest
that PIM-1 is involved in the survival, migration, and matrix-degradation of
RA-FLS and PIM-1 could be a potential target for RA treatment.

Fig. 1. The immunohistochemical
staining of PIM-1 kinase in the synovial tissue from 2 RA and 2 OA patients.

Fig. 2. The effect of PIM-1
on RA-FLS. (a) Under the stimulation with TNF-a,
proliferation and migration was significantly inhibited in PIM-1
siRNA-transfected RA-FLS. (b) PIM-1 knockdown also significantly suppressed the
secretion of MMP-1, MMP-3, and MMP-13 from RA-FLS stimulated with TNF-a in serum-free media.


Disclosure: Y. S. Choi, None; Y. J. Ha, None; J. Hur, None; E. H. Kang, None; Y. W. Song, None; Y. J. Lee, None.

To cite this abstract in AMA style:

Choi YS, Ha YJ, Hur J, Kang EH, Song YW, Lee YJ. Expression and Function of Proviral Integration Site for Moloney Murine Leukemia Virus 1 (PIM-1) Kinase in Rheumatoid Arthritis Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/expression-and-function-of-proviral-integration-site-for-moloney-murine-leukemia-virus-1-pim-1-kinase-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/expression-and-function-of-proviral-integration-site-for-moloney-murine-leukemia-virus-1-pim-1-kinase-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology